Inventor
PETRI ANDREAS
DK21 patents
⚠️ This page may combine multiple inventors who share the name “PETRI ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE INNOVATION CT COPENHAGEN AS
7 patentsUS9879265B2Jan 30, 2018
Oligonucleotide conjugates
ROCHE INNOVATION CT COPENHAGEN AS17 citations92
US10443058B2Oct 15, 2019
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US10385342B2Aug 20, 2019
Methods of treatment using antisense oligomers and conjugates targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US10370668B2Aug 6, 2019
Manufacture of antisense oligomers and conjugates targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS1 citations71
US12421516B2Sep 23, 2025
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US11739332B2Aug 29, 2023
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
US11091764B2Aug 17, 2021
Antisense oligomers targeting PCSK9
ROCHE INNOVATION CT COPENHAGEN AS0 citations61
MASSACHUSETTS GEN HOSPITAL
4 patentsUS11236336B2Feb 1, 2022
Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy
MASSACHUSETTS GEN HOSPITAL0 citations61
US10626395B2Apr 21, 2020
Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy
MASSACHUSETTS GEN HOSPITAL1 citations61
US12152241B2Nov 26, 2024
Targeting human satellite II (HSATII)
MASSACHUSETTS GEN HOSPITAL1 citations58
US10301624B2May 28, 2019
Targeting human satellite II (HSATII)
MASSACHUSETTS GEN HOSPITAL1 citations58